| pubmed-article:11699610 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11699610 | lifeskim:mentions | umls-concept:C0042776 | lld:lifeskim |
| pubmed-article:11699610 | lifeskim:mentions | umls-concept:C0684336 | lld:lifeskim |
| pubmed-article:11699610 | lifeskim:mentions | umls-concept:C0025519 | lld:lifeskim |
| pubmed-article:11699610 | lifeskim:mentions | umls-concept:C0012586 | lld:lifeskim |
| pubmed-article:11699610 | lifeskim:mentions | umls-concept:C0231221 | lld:lifeskim |
| pubmed-article:11699610 | lifeskim:mentions | umls-concept:C1742737 | lld:lifeskim |
| pubmed-article:11699610 | lifeskim:mentions | umls-concept:C1709305 | lld:lifeskim |
| pubmed-article:11699610 | lifeskim:mentions | umls-concept:C0439831 | lld:lifeskim |
| pubmed-article:11699610 | pubmed:issue | 6-7 | lld:pubmed |
| pubmed-article:11699610 | pubmed:dateCreated | 2001-11-8 | lld:pubmed |
| pubmed-article:11699610 | pubmed:abstractText | We previously found that, compared with healthy subjects. asymptomatic hepatitis-B virus (HBV) carriers displaying slow acetylator phenotype demonstrate a significant prolongation of the elimination half-life of 4-methylaminoantipyrine (MAA) and a decrease in the clearance of formation of 4-aminoantipyrine (AA) and 4-formylaminoantipyrine (FAA). However, the formation of 4-acetylaminoantipyrine (AAA) was unchanged. The present study was designed to examine the effect of the asymptomatic HBV carrier state on the metabolism of dipyrone. as a model drug, in rapid acetylators. | lld:pubmed |
| pubmed-article:11699610 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11699610 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11699610 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11699610 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11699610 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11699610 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11699610 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11699610 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11699610 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11699610 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11699610 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11699610 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11699610 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:11699610 | pubmed:issn | 0031-6970 | lld:pubmed |
| pubmed-article:11699610 | pubmed:author | pubmed-author:LevyMM | lld:pubmed |
| pubmed-article:11699610 | pubmed:author | pubmed-author:Zylber-KatzEE | lld:pubmed |
| pubmed-article:11699610 | pubmed:author | pubmed-author:GranitLL | lld:pubmed |
| pubmed-article:11699610 | pubmed:author | pubmed-author:CaracoYY | lld:pubmed |
| pubmed-article:11699610 | pubmed:author | pubmed-author:SafadiRR | lld:pubmed |
| pubmed-article:11699610 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11699610 | pubmed:volume | 57 | lld:pubmed |
| pubmed-article:11699610 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11699610 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11699610 | pubmed:pagination | 461-5 | lld:pubmed |
| pubmed-article:11699610 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11699610 | pubmed:meshHeading | pubmed-meshheading:11699610... | lld:pubmed |
| pubmed-article:11699610 | pubmed:meshHeading | pubmed-meshheading:11699610... | lld:pubmed |
| pubmed-article:11699610 | pubmed:meshHeading | pubmed-meshheading:11699610... | lld:pubmed |
| pubmed-article:11699610 | pubmed:meshHeading | pubmed-meshheading:11699610... | lld:pubmed |
| pubmed-article:11699610 | pubmed:meshHeading | pubmed-meshheading:11699610... | lld:pubmed |
| pubmed-article:11699610 | pubmed:meshHeading | pubmed-meshheading:11699610... | lld:pubmed |
| pubmed-article:11699610 | pubmed:meshHeading | pubmed-meshheading:11699610... | lld:pubmed |
| pubmed-article:11699610 | pubmed:meshHeading | pubmed-meshheading:11699610... | lld:pubmed |
| pubmed-article:11699610 | pubmed:meshHeading | pubmed-meshheading:11699610... | lld:pubmed |
| pubmed-article:11699610 | pubmed:meshHeading | pubmed-meshheading:11699610... | lld:pubmed |
| pubmed-article:11699610 | pubmed:meshHeading | pubmed-meshheading:11699610... | lld:pubmed |
| pubmed-article:11699610 | pubmed:meshHeading | pubmed-meshheading:11699610... | lld:pubmed |
| pubmed-article:11699610 | pubmed:meshHeading | pubmed-meshheading:11699610... | lld:pubmed |
| pubmed-article:11699610 | pubmed:meshHeading | pubmed-meshheading:11699610... | lld:pubmed |
| pubmed-article:11699610 | pubmed:meshHeading | pubmed-meshheading:11699610... | lld:pubmed |
| pubmed-article:11699610 | pubmed:meshHeading | pubmed-meshheading:11699610... | lld:pubmed |
| pubmed-article:11699610 | pubmed:meshHeading | pubmed-meshheading:11699610... | lld:pubmed |
| pubmed-article:11699610 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11699610 | pubmed:articleTitle | Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis-B virus does not occur in rapid acetylators. | lld:pubmed |
| pubmed-article:11699610 | pubmed:affiliation | Department of Medicine, Hadassah University Hospital, Jerusalem, Israel. mlevy@md.huji.ac.il | lld:pubmed |
| pubmed-article:11699610 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11699610 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11699610 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
